https://mappings.dbpedia.org/api.php?action=feedcontributions&feedformat=atom&user=Boycer 2026-05-14T23:42:04Z User contributions MediaWiki 1.39.4 https://mappings.dbpedia.org/index.php?title=User:Boycer&diff=19143 2012-07-31T13:00:05Z

<p>Boycer: </p> <hr /> <div>Richard Boyce, PhD<br /> <br /> Assistant Professor of Biomedical Informatics<br /> <br /> Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program<br /> <br /> Scholar, Comparative Effectiveness Research Program<br /> <br /> University of Pittsburgh<br /> <br /> [http://www.dbmi.pitt.edu/person/richard-boyce-phd www.dbmi.pitt.edu/person/richard-boyce-phd Homepage]<br /> <br /> Twitter: @bhaapgh</div>

Boycer https://mappings.dbpedia.org/index.php?title=User:Boycer&diff=19142 2012-07-31T12:59:19Z

<p>Boycer: Created page with 'Richard Boyce, PhD Assistant Professor of Biomedical Informatics Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program Scholar, Comparativ...'</p> <hr /> <div>Richard Boyce, PhD<br /> Assistant Professor of Biomedical Informatics<br /> Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program<br /> Scholar, Comparative Effectiveness Research Program<br /> University of Pittsburgh<br /> [http://www.dbmi.pitt.edu/person/richard-boyce-phd www.dbmi.pitt.edu/person/richard-boyce-phd Homepage]<br /> Twitter: @bhaapgh</div>

Boycer https://mappings.dbpedia.org/index.php?title=Mapping_en:Drugbox&diff=19141 2012-07-31T12:56:02Z

<p>Boycer: </p> <hr /> <div>{{TemplateMapping<br /> | mapToClass = Drug<br /> | mappings =<br /> {{PropertyMapping | templateProperty = IUPAC_name | ontologyProperty = iupacName }}<br /> {{PropertyMapping | templateProperty = CAS_number | ontologyProperty = casNumber }}<br /> {{PropertyMapping | templateProperty = CAS_supplemental | ontologyProperty = casSupplemental }}<br /> {{PropertyMapping | templateProperty = ATC_prefix | ontologyProperty = atcPrefix }}<br /> {{PropertyMapping | templateProperty = ATC_suffix | ontologyProperty = atcSuffix }}<br /> {{PropertyMapping | templateProperty = ATC_supplemental | ontologyProperty = atcSupplemental }}<br /> {{PropertyMapping | templateProperty = PubChem | ontologyProperty = pubchem }}<br /> {{PropertyMapping | templateProperty = DrugBank | ontologyProperty = drugbank }}<br /> {{PropertyMapping | templateProperty = melting_point | ontologyProperty = meltingPoint | unit = Temperature }}<br /> {{PropertyMapping | templateProperty = melting_high | ontologyProperty = meltingPoint | unit = Temperature }}<br /> {{PropertyMapping | templateProperty = boiling_point | ontologyProperty = boilingPoint | unit = Temperature }}<br /> {{PropertyMapping | templateProperty = drug_name | ontologyProperty = foaf:name }}<br /> {{PropertyMapping | templateProperty = UNII | ontologyProperty = fdaUniiCode }}<br /> {{PropertyMapping | templateProperty = bioavailability | ontologyProperty = bioavailability}}<br /> {{PropertyMapping | templateProperty = ChEBI | ontologyProperty = ChEBI}}<br /> }}</div>

Boycer https://mappings.dbpedia.org/index.php?title=OntologyProperty:ChEBI&diff=19140 2012-07-31T12:54:37Z

<p>Boycer: Created page with '{{DatatypeProperty | rdfs:label@en = ChEBI | rdfs:comment@en = A unique identifier for the drug in the Chemical Entities of Biological Interest (ChEBI) ontology | rdfs:domain = D...'</p> <hr /> <div>{{DatatypeProperty<br /> | rdfs:label@en = ChEBI<br /> | rdfs:comment@en = A unique identifier for the drug in the Chemical Entities of Biological Interest (ChEBI) ontology<br /> | rdfs:domain = Drug<br /> | rdfs:range = xsd:string<br /> }}</div>

Boycer https://mappings.dbpedia.org/index.php?title=OntologyProperty:Bioavailability&diff=19139 2012-07-31T12:49:35Z

<p>Boycer: </p> <hr /> <div>{{DatatypeProperty<br /> | rdfs:label@en = Bioavailability<br /> | rdfs:comment@en = &quot;The rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action (21CFR320.1).&quot;<br /> | rdfs:domain = Drug<br /> | rdfs:range = xsd:float<br /> | owl:equivalentProperty = &lt;http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#bioavailability&gt;<br /> }}</div>

Boycer https://mappings.dbpedia.org/index.php?title=OntologyProperty:Bioavailability&diff=19138 2012-07-31T12:48:06Z

<p>Boycer: </p> <hr /> <div>{{DatatypeProperty<br /> | rdfs:label@en = Bioavailability<br /> | rdfs:comment@en = &quot;The rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action (21CFR320.1).&quot;<br /> | rdfs:domain = Drug<br /> | rdfs:range = xsd:float<br /> | owl:equivalentProperty = ncbit:bioavailability<br /> }}</div>

Boycer https://mappings.dbpedia.org/index.php?title=Mapping_en:Drugbox&diff=19137 2012-07-31T12:47:16Z

<p>Boycer: </p> <hr /> <div>{{TemplateMapping<br /> | mapToClass = Drug<br /> | mappings =<br /> {{PropertyMapping | templateProperty = IUPAC_name | ontologyProperty = iupacName }}<br /> {{PropertyMapping | templateProperty = CAS_number | ontologyProperty = casNumber }}<br /> {{PropertyMapping | templateProperty = CAS_supplemental | ontologyProperty = casSupplemental }}<br /> {{PropertyMapping | templateProperty = ATC_prefix | ontologyProperty = atcPrefix }}<br /> {{PropertyMapping | templateProperty = ATC_suffix | ontologyProperty = atcSuffix }}<br /> {{PropertyMapping | templateProperty = ATC_supplemental | ontologyProperty = atcSupplemental }}<br /> {{PropertyMapping | templateProperty = PubChem | ontologyProperty = pubchem }}<br /> {{PropertyMapping | templateProperty = DrugBank | ontologyProperty = drugbank }}<br /> {{PropertyMapping | templateProperty = melting_point | ontologyProperty = meltingPoint | unit = Temperature }}<br /> {{PropertyMapping | templateProperty = melting_high | ontologyProperty = meltingPoint | unit = Temperature }}<br /> {{PropertyMapping | templateProperty = boiling_point | ontologyProperty = boilingPoint | unit = Temperature }}<br /> {{PropertyMapping | templateProperty = drug_name | ontologyProperty = foaf:name }}<br /> {{PropertyMapping | templateProperty = UNII | ontologyProperty = fdaUniiCode }}<br /> {{PropertyMapping | templateProperty = bioavailability | ontologyProperty = bioavailability}}<br /> }}</div>

Boycer https://mappings.dbpedia.org/index.php?title=OntologyProperty:Bioavailability&diff=19136 2012-07-31T12:43:07Z

<p>Boycer: Created page with '{{DatatypeProperty | rdfs:label@en = Bioavailability | rdfs:comment@en = &quot;The rate and extent to which the active ingredient or active moiety is absorbed from a drug product and ...'</p> <hr /> <div>{{DatatypeProperty<br /> | rdfs:label@en = Bioavailability<br /> | rdfs:comment@en = &quot;The rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action (21CFR320.1).&quot;<br /> | rdfs:domain = Drug<br /> | rdfs:range = xsd:float<br /> }}</div>

Boycer